HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and evaluation of dihydropyrroloquinolines that selectively antagonize P-glycoprotein.

Abstract
In a search for improved multiple drug resistance (MDR) modulators, we identified a novel series of substituted pyrroloquinolines that selectively inhibits the function of P-glycoprotein (Pgp) without modulating multidrug resistance-related protein 1 (MRP1). These compounds were evaluated for their toxicity toward drug-sensitive tumor cells (i.e. MCF-7, T24) and for their ability to antagonize Pgp-mediated drug-resistant cells (i.e. NCI/ADR) and MRP1-mediated resistant cells (i.e. MCF-7/VP). Cytotoxicity and drug accumulation assays demonstrated that the dihydropyrroloquinolines inhibit Pgp to varying degrees, without any significant inhibition of MRP1. The compound termed PGP-4008 was the most effective at inhibiting Pgp in vitro and was further evaluated in vivo. PGP-4008 inhibited tumor growth in a murine syngeneic Pgp-mediated MDR solid tumor model when given in combination with doxorubicin. PGP-4008 was rapidly absorbed after intraperitoneal administration, with its plasma concentrations exceeding the in vitro effective dose for more than 2 h. PGP-4008 did not alter the plasma distribution of concomitantly administered anticancer drugs and did not cause systemic toxicity as was observed for cyclosporin A. Because of their enhanced selectivity toward Pgp, these substituted dihydropyrroloquinolines may be effective MDR modulators in a clinical setting.
AuthorsBrian D Lee, Zhanjiang Li, Kevin J French, Yan Zhuang, Zuping Xia, Charles D Smith
JournalJournal of medicinal chemistry (J Med Chem) Vol. 47 Issue 6 Pg. 1413-22 (Mar 11 2004) ISSN: 0022-2623 [Print] United States
PMID14998330 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Acetanilides
  • Antineoplastic Agents
  • Multidrug Resistance-Associated Proteins
  • N-1-benzyl-2,3-dihydro-1H-pyrrolo(2,3-b)quinolin-4-yl-2-phenylacetamide
  • Pyrroles
  • Quinolines
Topics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 (antagonists & inhibitors)
  • Acetanilides
  • Animals
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Area Under Curve
  • Cell Line, Tumor
  • Drug Resistance, Multiple
  • Drug Screening Assays, Antitumor
  • Female
  • Half-Life
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Multidrug Resistance-Associated Proteins (antagonists & inhibitors)
  • Neoplasm Transplantation
  • Pyrroles (chemical synthesis, chemistry, pharmacology)
  • Quinolines (chemical synthesis, chemistry, pharmacology)
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: